24 news items
From Comfort to Cure: 2024 ASCO Meeting Reveals Groundbreaking Oncology Data
ABBV
AZN
BMY
19 Jun 24
should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because
From Comfort to Cure: 2024 ASCO Meeting Reveals Groundbreaking Oncology Data
ABBV
AZN
BMY
19 Jun 24
. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also
U.S. Food and Drug Administration Approves Augtyroâ„¢ (repotrectinib), a Next-Generation Tyrosine Kinase Inhibitor (TKI), for the Treatment of Patients with NTRK-Positive Locally Advanced or Metastatic Solid Tumors
BMY
13 Jun 24
tumor cohorts has a primary endpoint of objective response rate (ORR) as assessed by Blinded Independent Central Review (BICR
FDA Approves Geron's First Commercial Drug, Competes With Bristol Myers Squibb's Blood Cancer Drug
BMY
GERN
7 Jun 24
secondary endpoints, with Rytelo demonstrating significantly higher rates of red blood cell transfusion independence (RBC-TI) versus placebo
KRAZATI (adagrasib) Demonstrated Statistically Significant Improvement in Progression-Free Survival in Patients with Pretreated Locally Advanced or Metastatic KRASG12C-Mutated Non-Small Cell Lung Cancer
BMY
1 Jun 24
, as assessed by Blinded Independent Central Review (BICR) compared to docetaxel (HR: 0.58; [95% CI, 0.45-0.76]; P <0.0001). Median PFS was 5.5 months
7yx68s
BMY
CCCC
ONCY
28 May 24
is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely
9i7n7f7 98aca0nss7if
BMY
CCCC
ONCY
28 May 24
is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected
lrx23zf28fzuid7y2r5iwi0j31ywcr4bfi2i4vqy4 vbiw90wm8
BMY
23 May 24
transfusion independence and overall survival in lower-risk myelodysplastic syndromes
oimq9nex6nh3phrgh
BMY
21 May 24
independently, enjoys yoga and dance, and is doing really well. We want to get rid of the negative images many of us have of schizophrenia and raise
84d19da4299ya98f1qczaij1srja
BMY
15 May 24
or complete response per Lugano criteria as assessed by an Independent Review Committee (IRC). The complete response (CR) rate was 73.4% (95% CI: 63.3
1u3s1vtvi drucw4ss2lg062cuy2terwdu9px0cctjt07kizg
BMY
10 May 24
of the trial is progression-free survival (PFS) by RECIST 1.1 per blinded independent central review (BICR) for Arm A vs. Arm C. Secondary endpoints include
4k51 a7yyugzyjy0edghth3sa384rnvqg5tjhemv1mrzb3d
BMY
26 Apr 24
of overall survival (OS) and progression-free survival (PFS) as assessed by Blinded Independent Central Review (BICR). With a median follow up
2uegci
BMY
25 Apr 24
Independent
6zub04iszbtura66akm j10o1i0s3bqmbwbhemb78bfxzb
ABBV
ATNM
AZN
19 Apr 24
is neither an investment advisor nor a registered broker. No current owner, employee, or independent contractor of InvestorBrandMedia.com
xysmws6dj
ATNM
AZN
BMY
18 Apr 24
. No current owner, employee, or independent contractor of InvestorBrandMedia.com is registered as a securities broker-dealer, broker, investment advisor
kbeuyqqqabptgyjb0p9omxzx3hi zoyj78zuy9v87tqsqi8pms6v
ATNM
AZN
BMY
17 Apr 24
broker. No current owner, employee, or independent contractor of InvestorBrandMedia.com is registered as a securities broker-dealer, broker, investment
gmxj07ki84 3bac0gydog28b
BMY
6 Apr 24
, people living with schizophrenia often struggle to maintain employment, live independently, and manage relationships. While current treatments can